Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
- 20 November 2009
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 374 (9702), 1694-1702
- https://doi.org/10.1016/s0140-6736(09)61297-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A Randomized, Placebo-Controlled Trial of the Bivalent Killed, Whole-Cell, Oral Cholera Vaccine in Adults and Children in a Cholera Endemic Area in Kolkata, IndiaPLOS ONE, 2008
- Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adultsVaccine, 2007
- Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in VietnamVaccine, 2006
- Two‐Year Study of the Protective Efficacy of the Oral Whole Cell plus Recombinant B Subunit Cholera Vaccine in PeruThe Journal of Infectious Diseases, 2000
- Field trial of a locally produced, killed, oral cholera vaccine in VietnamThe Lancet, 1997
- Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruitsThe Lancet, 1994
- Direct and Indirect Effects in Vaccine Efficacy and EffectivenessAmerican Journal of Epidemiology, 1991
- FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESHThe Lancet, 1986
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Influence functions for proportional hazards regressionBiometrika, 1985